nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluoxymesterone—breast cancer—ovarian cancer	0.599	1	CtDrD
Fluoxymesterone—ESR1—ovarian cancer	0.264	1	CbGaD
Fluoxymesterone—ESR1—ovarian follicle—ovarian cancer	0.00493	0.0942	CbGeAlD
Fluoxymesterone—PRLR—myometrium—ovarian cancer	0.00456	0.087	CbGeAlD
Fluoxymesterone—PRLR—uterine cervix—ovarian cancer	0.00355	0.0677	CbGeAlD
Fluoxymesterone—PRLR—decidua—ovarian cancer	0.00338	0.0645	CbGeAlD
Fluoxymesterone—PRLR—endometrium—ovarian cancer	0.00321	0.0612	CbGeAlD
Fluoxymesterone—PRLR—uterus—ovarian cancer	0.00296	0.0564	CbGeAlD
Fluoxymesterone—PRLR—female gonad—ovarian cancer	0.00242	0.0462	CbGeAlD
Fluoxymesterone—AR—oviduct—ovarian cancer	0.00221	0.0421	CbGeAlD
Fluoxymesterone—ESR1—oviduct—ovarian cancer	0.00217	0.0414	CbGeAlD
Fluoxymesterone—PRLR—testis—ovarian cancer	0.00214	0.0409	CbGeAlD
Fluoxymesterone—Coma hepatic—Docetaxel—ovarian cancer	0.00184	0.127	CcSEcCtD
Fluoxymesterone—Oligospermia—Epirubicin—ovarian cancer	0.000743	0.0514	CcSEcCtD
Fluoxymesterone—AR—myometrium—ovarian cancer	0.000706	0.0135	CbGeAlD
Fluoxymesterone—ESR1—myometrium—ovarian cancer	0.000693	0.0132	CbGeAlD
Fluoxymesterone—SHBG—endometrium—ovarian cancer	0.000692	0.0132	CbGeAlD
Fluoxymesterone—Oligospermia—Doxorubicin—ovarian cancer	0.000688	0.0475	CcSEcCtD
Fluoxymesterone—ESR1—embryo—ovarian cancer	0.000667	0.0127	CbGeAlD
Fluoxymesterone—SHBG—gonad—ovarian cancer	0.000642	0.0123	CbGeAlD
Fluoxymesterone—SHBG—uterus—ovarian cancer	0.000638	0.0122	CbGeAlD
Fluoxymesterone—Amenorrhoea—Chlorambucil—ovarian cancer	0.000605	0.0418	CcSEcCtD
Fluoxymesterone—Azoospermia—Epirubicin—ovarian cancer	0.000578	0.04	CcSEcCtD
Fluoxymesterone—SHBG—female reproductive system—ovarian cancer	0.000574	0.011	CbGeAlD
Fluoxymesterone—AR—epithelium—ovarian cancer	0.000554	0.0106	CbGeAlD
Fluoxymesterone—AR—uterine cervix—ovarian cancer	0.000549	0.0105	CbGeAlD
Fluoxymesterone—ESR1—epithelium—ovarian cancer	0.000544	0.0104	CbGeAlD
Fluoxymesterone—SHBG—bone marrow—ovarian cancer	0.000542	0.0103	CbGeAlD
Fluoxymesterone—ESR1—uterine cervix—ovarian cancer	0.000539	0.0103	CbGeAlD
Fluoxymesterone—Azoospermia—Doxorubicin—ovarian cancer	0.000535	0.037	CcSEcCtD
Fluoxymesterone—Amenorrhoea—Melphalan—ovarian cancer	0.000527	0.0365	CcSEcCtD
Fluoxymesterone—AR—decidua—ovarian cancer	0.000524	0.01	CbGeAlD
Fluoxymesterone—SHBG—female gonad—ovarian cancer	0.000522	0.00997	CbGeAlD
Fluoxymesterone—SHBG—vagina—ovarian cancer	0.000519	0.00991	CbGeAlD
Fluoxymesterone—ESR1—decidua—ovarian cancer	0.000514	0.00981	CbGeAlD
Fluoxymesterone—NR3C1—myometrium—ovarian cancer	0.000511	0.00977	CbGeAlD
Fluoxymesterone—AR—endometrium—ovarian cancer	0.000497	0.00949	CbGeAlD
Fluoxymesterone—Dydrogesterone—PGR—ovarian cancer	0.000496	0.177	CrCbGaD
Fluoxymesterone—NR3C1—embryo—ovarian cancer	0.000492	0.00939	CbGeAlD
Fluoxymesterone—ESR1—endometrium—ovarian cancer	0.000488	0.00932	CbGeAlD
Fluoxymesterone—SHBG—testis—ovarian cancer	0.000463	0.00884	CbGeAlD
Fluoxymesterone—AR—gonad—ovarian cancer	0.000461	0.0088	CbGeAlD
Fluoxymesterone—AR—uterus—ovarian cancer	0.000458	0.00874	CbGeAlD
Fluoxymesterone—ESR1—gonad—ovarian cancer	0.000453	0.00864	CbGeAlD
Fluoxymesterone—ESR1—uterus—ovarian cancer	0.00045	0.00858	CbGeAlD
Fluoxymesterone—Menstruation irregular—Docetaxel—ovarian cancer	0.000417	0.0288	CcSEcCtD
Fluoxymesterone—AR—female reproductive system—ovarian cancer	0.000412	0.00786	CbGeAlD
Fluoxymesterone—ESR1—female reproductive system—ovarian cancer	0.000404	0.00772	CbGeAlD
Fluoxymesterone—NR3C1—epithelium—ovarian cancer	0.000401	0.00766	CbGeAlD
Fluoxymesterone—NR3C1—uterine cervix—ovarian cancer	0.000398	0.0076	CbGeAlD
Fluoxymesterone—NR3C1—decidua—ovarian cancer	0.000379	0.00724	CbGeAlD
Fluoxymesterone—AR—female gonad—ovarian cancer	0.000375	0.00715	CbGeAlD
Fluoxymesterone—AR—vagina—ovarian cancer	0.000372	0.00711	CbGeAlD
Fluoxymesterone—ESR1—female gonad—ovarian cancer	0.000368	0.00702	CbGeAlD
Fluoxymesterone—ESR1—vagina—ovarian cancer	0.000366	0.00698	CbGeAlD
Fluoxymesterone—NR3C1—endometrium—ovarian cancer	0.00036	0.00687	CbGeAlD
Fluoxymesterone—Anaphylactoid reaction—Topotecan—ovarian cancer	0.000355	0.0245	CcSEcCtD
Fluoxymesterone—NR3C1—gonad—ovarian cancer	0.000334	0.00638	CbGeAlD
Fluoxymesterone—AR—testis—ovarian cancer	0.000332	0.00634	CbGeAlD
Fluoxymesterone—NR3C1—uterus—ovarian cancer	0.000332	0.00633	CbGeAlD
Fluoxymesterone—ESR1—testis—ovarian cancer	0.000326	0.00623	CbGeAlD
Fluoxymesterone—Nausea—Altretamine—ovarian cancer	0.000317	0.0219	CcSEcCtD
Fluoxymesterone—Megestrol acetate—PGR—ovarian cancer	0.000298	0.106	CrCbGaD
Fluoxymesterone—NR3C1—female reproductive system—ovarian cancer	0.000298	0.00569	CbGeAlD
Fluoxymesterone—NR3C1—bone marrow—ovarian cancer	0.000281	0.00538	CbGeAlD
Fluoxymesterone—NR3C1—female gonad—ovarian cancer	0.000271	0.00518	CbGeAlD
Fluoxymesterone—NR3C1—vagina—ovarian cancer	0.00027	0.00515	CbGeAlD
Fluoxymesterone—Amenorrhoea—Docetaxel—ovarian cancer	0.000263	0.0182	CcSEcCtD
Fluoxymesterone—AR—lymph node—ovarian cancer	0.000241	0.0046	CbGeAlD
Fluoxymesterone—NR3C1—testis—ovarian cancer	0.000241	0.0046	CbGeAlD
Fluoxymesterone—Haemoglobin—Topotecan—ovarian cancer	0.000239	0.0165	CcSEcCtD
Fluoxymesterone—Haemorrhage—Topotecan—ovarian cancer	0.000238	0.0164	CcSEcCtD
Fluoxymesterone—ESR1—lymph node—ovarian cancer	0.000236	0.00451	CbGeAlD
Fluoxymesterone—Alopecia—Chlorambucil—ovarian cancer	0.000236	0.0163	CcSEcCtD
Fluoxymesterone—Haemoglobin—Melphalan—ovarian cancer	0.000234	0.0162	CcSEcCtD
Fluoxymesterone—Haemorrhage—Melphalan—ovarian cancer	0.000233	0.0161	CcSEcCtD
Fluoxymesterone—Seborrhoeic dermatitis—Epirubicin—ovarian cancer	0.000228	0.0158	CcSEcCtD
Fluoxymesterone—Seborrhoeic dermatitis—Doxorubicin—ovarian cancer	0.000211	0.0146	CcSEcCtD
Fluoxymesterone—Alopecia—Topotecan—ovarian cancer	0.00021	0.0145	CcSEcCtD
Fluoxymesterone—Alopecia—Melphalan—ovarian cancer	0.000206	0.0142	CcSEcCtD
Fluoxymesterone—Danazol—PGR—ovarian cancer	0.000194	0.069	CrCbGaD
Fluoxymesterone—Spironolactone—PGR—ovarian cancer	0.000185	0.0661	CrCbGaD
Fluoxymesterone—Alopecia—Vinorelbine—ovarian cancer	0.00018	0.0124	CcSEcCtD
Fluoxymesterone—Jaundice cholestatic—Epirubicin—ovarian cancer	0.000177	0.0123	CcSEcCtD
Fluoxymesterone—Amenorrhoea—Epirubicin—ovarian cancer	0.000177	0.0123	CcSEcCtD
Fluoxymesterone—NR3C1—lymph node—ovarian cancer	0.000174	0.00333	CbGeAlD
Fluoxymesterone—Medroxyprogesterone Acetate—PGR—ovarian cancer	0.000174	0.062	CrCbGaD
Fluoxymesterone—Norethindrone—PGR—ovarian cancer	0.000172	0.0614	CrCbGaD
Fluoxymesterone—Anaphylactic shock—Topotecan—ovarian cancer	0.000169	0.0117	CcSEcCtD
Fluoxymesterone—Anaphylactic shock—Melphalan—ovarian cancer	0.000165	0.0114	CcSEcCtD
Fluoxymesterone—Amenorrhoea—Doxorubicin—ovarian cancer	0.000164	0.0113	CcSEcCtD
Fluoxymesterone—Jaundice cholestatic—Doxorubicin—ovarian cancer	0.000164	0.0113	CcSEcCtD
Fluoxymesterone—Betamethasone—PGR—ovarian cancer	0.000158	0.0563	CrCbGaD
Fluoxymesterone—Paraesthesia—Topotecan—ovarian cancer	0.000152	0.0105	CcSEcCtD
Fluoxymesterone—Paraesthesia—Melphalan—ovarian cancer	0.000148	0.0103	CcSEcCtD
Fluoxymesterone—Anaphylactic shock—Vinorelbine—ovarian cancer	0.000144	0.00999	CcSEcCtD
Fluoxymesterone—Hypersensitivity—Chlorambucil—ovarian cancer	0.00014	0.00966	CcSEcCtD
Fluoxymesterone—Haemoglobin—Paclitaxel—ovarian cancer	0.000137	0.0095	CcSEcCtD
Fluoxymesterone—Haemorrhage—Paclitaxel—ovarian cancer	0.000137	0.00946	CcSEcCtD
Fluoxymesterone—Paraesthesia—Vinorelbine—ovarian cancer	0.00013	0.00897	CcSEcCtD
Fluoxymesterone—Hypersensitivity—Topotecan—ovarian cancer	0.000124	0.0086	CcSEcCtD
Fluoxymesterone—Danazol—ESR1—ovarian cancer	0.000122	0.0436	CrCbGaD
Fluoxymesterone—Hypersensitivity—Melphalan—ovarian cancer	0.000122	0.00842	CcSEcCtD
Fluoxymesterone—Alopecia—Paclitaxel—ovarian cancer	0.000121	0.00836	CcSEcCtD
Fluoxymesterone—Anaphylactoid reaction—Epirubicin—ovarian cancer	0.000117	0.00807	CcSEcCtD
Fluoxymesterone—Haemoglobin—Docetaxel—ovarian cancer	0.000117	0.00805	CcSEcCtD
Fluoxymesterone—Haemorrhage—Docetaxel—ovarian cancer	0.000116	0.00801	CcSEcCtD
Fluoxymesterone—Nausea—Chlorambucil—ovarian cancer	0.000113	0.00779	CcSEcCtD
Fluoxymesterone—Medroxyprogesterone Acetate—ESR1—ovarian cancer	0.00011	0.0391	CrCbGaD
Fluoxymesterone—Anaphylactoid reaction—Doxorubicin—ovarian cancer	0.000108	0.00747	CcSEcCtD
Fluoxymesterone—Hypersensitivity—Vinorelbine—ovarian cancer	0.000106	0.00736	CcSEcCtD
Fluoxymesterone—Headache—Topotecan—ovarian cancer	0.000106	0.00731	CcSEcCtD
Fluoxymesterone—Alopecia—Docetaxel—ovarian cancer	0.000102	0.00708	CcSEcCtD
Fluoxymesterone—Anxiety—Paclitaxel—ovarian cancer	0.000101	0.00698	CcSEcCtD
Fluoxymesterone—Progesterone—PGR—ovarian cancer	0.0001	0.0358	CrCbGaD
Fluoxymesterone—Nausea—Topotecan—ovarian cancer	0.0001	0.00693	CcSEcCtD
Fluoxymesterone—Nausea—Melphalan—ovarian cancer	9.82e-05	0.00679	CcSEcCtD
Fluoxymesterone—Anaphylactic shock—Paclitaxel—ovarian cancer	9.72e-05	0.00672	CcSEcCtD
Fluoxymesterone—Progesterone—CYP1B1—ovarian cancer	9.38e-05	0.0334	CrCbGaD
Fluoxymesterone—Dexamethasone—PGR—ovarian cancer	9.18e-05	0.0327	CrCbGaD
Fluoxymesterone—Headache—Vinorelbine—ovarian cancer	9.05e-05	0.00626	CcSEcCtD
Fluoxymesterone—Testosterone—CYP1B1—ovarian cancer	8.87e-05	0.0316	CrCbGaD
Fluoxymesterone—Paraesthesia—Paclitaxel—ovarian cancer	8.73e-05	0.00603	CcSEcCtD
Fluoxymesterone—Nausea—Vinorelbine—ovarian cancer	8.58e-05	0.00593	CcSEcCtD
Fluoxymesterone—Dexamethasone—CYP1B1—ovarian cancer	8.58e-05	0.0306	CrCbGaD
Fluoxymesterone—Anaphylactic shock—Docetaxel—ovarian cancer	8.24e-05	0.00569	CcSEcCtD
Fluoxymesterone—Megestrol acetate—ABCB1—ovarian cancer	8e-05	0.0285	CrCbGaD
Fluoxymesterone—Haemoglobin—Epirubicin—ovarian cancer	7.86e-05	0.00543	CcSEcCtD
Fluoxymesterone—Haemorrhage—Epirubicin—ovarian cancer	7.82e-05	0.00541	CcSEcCtD
Fluoxymesterone—Paraesthesia—Docetaxel—ovarian cancer	7.4e-05	0.00511	CcSEcCtD
Fluoxymesterone—Haemoglobin—Doxorubicin—ovarian cancer	7.27e-05	0.00503	CcSEcCtD
Fluoxymesterone—Haemorrhage—Doxorubicin—ovarian cancer	7.23e-05	0.005	CcSEcCtD
Fluoxymesterone—Hypersensitivity—Paclitaxel—ovarian cancer	7.16e-05	0.00495	CcSEcCtD
Fluoxymesterone—Alopecia—Epirubicin—ovarian cancer	6.91e-05	0.00478	CcSEcCtD
Fluoxymesterone—Alopecia—Doxorubicin—ovarian cancer	6.39e-05	0.00442	CcSEcCtD
Fluoxymesterone—Progesterone—ESR1—ovarian cancer	6.33e-05	0.0226	CrCbGaD
Fluoxymesterone—Headache—Paclitaxel—ovarian cancer	6.09e-05	0.00421	CcSEcCtD
Fluoxymesterone—Hypersensitivity—Docetaxel—ovarian cancer	6.07e-05	0.00419	CcSEcCtD
Fluoxymesterone—Anxiety—Epirubicin—ovarian cancer	5.77e-05	0.00399	CcSEcCtD
Fluoxymesterone—Nausea—Paclitaxel—ovarian cancer	5.77e-05	0.00399	CcSEcCtD
Fluoxymesterone—Anaphylactic shock—Epirubicin—ovarian cancer	5.56e-05	0.00384	CcSEcCtD
Fluoxymesterone—Anxiety—Doxorubicin—ovarian cancer	5.34e-05	0.00369	CcSEcCtD
Fluoxymesterone—Headache—Docetaxel—ovarian cancer	5.16e-05	0.00357	CcSEcCtD
Fluoxymesterone—Anaphylactic shock—Doxorubicin—ovarian cancer	5.14e-05	0.00355	CcSEcCtD
Fluoxymesterone—Paraesthesia—Epirubicin—ovarian cancer	4.99e-05	0.00345	CcSEcCtD
Fluoxymesterone—Spironolactone—ABCB1—ovarian cancer	4.97e-05	0.0177	CrCbGaD
Fluoxymesterone—Nausea—Docetaxel—ovarian cancer	4.89e-05	0.00338	CcSEcCtD
Fluoxymesterone—Norethindrone—ABCB1—ovarian cancer	4.62e-05	0.0165	CrCbGaD
Fluoxymesterone—Paraesthesia—Doxorubicin—ovarian cancer	4.62e-05	0.00319	CcSEcCtD
Fluoxymesterone—AR—Androgen receptor signaling pathway—EGFR—ovarian cancer	4.38e-05	0.00065	CbGpPWpGaD
Fluoxymesterone—AR—Generic Transcription Pathway—PGR—ovarian cancer	4.34e-05	0.000646	CbGpPWpGaD
Fluoxymesterone—Prednisolone—ABCB1—ovarian cancer	4.32e-05	0.0154	CrCbGaD
Fluoxymesterone—ESR1—Regulation of Telomerase—MYC—ovarian cancer	4.27e-05	0.000635	CbGpPWpGaD
Fluoxymesterone—ESR1—Leptin signaling pathway—STAT3—ovarian cancer	4.25e-05	0.000632	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—IL6ST—ovarian cancer	4.25e-05	0.000631	CbGpPWpGaD
Fluoxymesterone—Betamethasone—ABCB1—ovarian cancer	4.23e-05	0.0151	CrCbGaD
Fluoxymesterone—PRLR—Signaling Pathways—PPP2R1A—ovarian cancer	4.21e-05	0.000625	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—NR5A1—ovarian cancer	4.2e-05	0.000624	CbGpPWpGaD
Fluoxymesterone—AR—Coregulation of Androgen receptor activity—AKT1—ovarian cancer	4.2e-05	0.000624	CbGpPWpGaD
Fluoxymesterone—ESR1—Regulation of Telomerase—MAPK1—ovarian cancer	4.18e-05	0.000622	CbGpPWpGaD
Fluoxymesterone—ESR1—Regulation of Telomerase—EGFR—ovarian cancer	4.18e-05	0.000621	CbGpPWpGaD
Fluoxymesterone—ESR1—AP-1 transcription factor network—MYC—ovarian cancer	4.18e-05	0.000621	CbGpPWpGaD
Fluoxymesterone—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—ovarian cancer	4.14e-05	0.000615	CbGpPWpGaD
Fluoxymesterone—NR3C1—AP-1 transcription factor network—MYC—ovarian cancer	4.11e-05	0.000611	CbGpPWpGaD
Fluoxymesterone—Hypersensitivity—Epirubicin—ovarian cancer	4.09e-05	0.00283	CcSEcCtD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—MTOR—ovarian cancer	4.08e-05	0.000607	CbGpPWpGaD
Fluoxymesterone—ESR1—Leptin signaling pathway—MAPK3—ovarian cancer	4.06e-05	0.000604	CbGpPWpGaD
Fluoxymesterone—AR—Generic Transcription Pathway—PARP1—ovarian cancer	4.04e-05	0.0006	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—CDH1—ovarian cancer	4.01e-05	0.000596	CbGpPWpGaD
Fluoxymesterone—ESR1—Leptin signaling pathway—MAPK1—ovarian cancer	3.87e-05	0.000575	CbGpPWpGaD
Fluoxymesterone—ESR1—Generic Transcription Pathway—YAP1—ovarian cancer	3.83e-05	0.00057	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—PIK3CD—ovarian cancer	3.83e-05	0.000569	CbGpPWpGaD
Fluoxymesterone—AR—SIDS Susceptibility Pathways—CXCL8—ovarian cancer	3.82e-05	0.000568	CbGpPWpGaD
Fluoxymesterone—Hypersensitivity—Doxorubicin—ovarian cancer	3.79e-05	0.00262	CcSEcCtD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—CDH1—ovarian cancer	3.78e-05	0.000561	CbGpPWpGaD
Fluoxymesterone—NR3C1—Generic Transcription Pathway—YAP1—ovarian cancer	3.77e-05	0.000561	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—CASP3—ovarian cancer	3.75e-05	0.000558	CbGpPWpGaD
Fluoxymesterone—NR3C1—Glucocorticoid receptor regulatory network—MAPK3—ovarian cancer	3.73e-05	0.000554	CbGpPWpGaD
Fluoxymesterone—ESR1—Regulation of nuclear SMAD2/3 signaling—MYC—ovarian cancer	3.72e-05	0.000552	CbGpPWpGaD
Fluoxymesterone—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—ovarian cancer	3.66e-05	0.000544	CbGpPWpGaD
Fluoxymesterone—AR—SIDS Susceptibility Pathways—CASP3—ovarian cancer	3.66e-05	0.000544	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—CCND1—ovarian cancer	3.65e-05	0.000543	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—CTNNB1—ovarian cancer	3.62e-05	0.000538	CbGpPWpGaD
Fluoxymesterone—ESR1—ATF-2 transcription factor network—IL6—ovarian cancer	3.6e-05	0.000535	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—PIK3CD—ovarian cancer	3.59e-05	0.000533	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—TTF1—ovarian cancer	3.56e-05	0.00053	CbGpPWpGaD
Fluoxymesterone—NR3C1—Glucocorticoid receptor regulatory network—MAPK1—ovarian cancer	3.55e-05	0.000527	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—PTEN—ovarian cancer	3.53e-05	0.000524	CbGpPWpGaD
Fluoxymesterone—AR—SIDS Susceptibility Pathways—CTNNB1—ovarian cancer	3.53e-05	0.000524	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—TTF1—ovarian cancer	3.51e-05	0.000522	CbGpPWpGaD
Fluoxymesterone—Headache—Epirubicin—ovarian cancer	3.48e-05	0.00241	CcSEcCtD
Fluoxymesterone—ESR1—Signaling Pathways—HSD17B6—ovarian cancer	3.47e-05	0.000516	CbGpPWpGaD
Fluoxymesterone—ESR1—AP-1 transcription factor network—TP53—ovarian cancer	3.43e-05	0.00051	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—ERBB2—ovarian cancer	3.43e-05	0.000509	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—APC—ovarian cancer	3.4e-05	0.000505	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—ERBB2—ovarian cancer	3.38e-05	0.000503	CbGpPWpGaD
Fluoxymesterone—NR3C1—AP-1 transcription factor network—TP53—ovarian cancer	3.38e-05	0.000502	CbGpPWpGaD
Fluoxymesterone—ESR1—Generic Transcription Pathway—PGR—ovarian cancer	3.35e-05	0.000497	CbGpPWpGaD
Fluoxymesterone—AR—Regulation of nuclear SMAD2/3 signaling—AKT1—ovarian cancer	3.35e-05	0.000497	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—TERT—ovarian cancer	3.34e-05	0.000497	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—PIK3CB—ovarian cancer	3.34e-05	0.000496	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—MTOR—ovarian cancer	3.34e-05	0.000496	CbGpPWpGaD
Fluoxymesterone—Hydrocortisone—ABCB1—ovarian cancer	3.3e-05	0.0118	CrCbGaD
Fluoxymesterone—Nausea—Epirubicin—ovarian cancer	3.3e-05	0.00228	CcSEcCtD
Fluoxymesterone—NR3C1—Generic Transcription Pathway—PGR—ovarian cancer	3.3e-05	0.00049	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—NR5A1—ovarian cancer	3.24e-05	0.000481	CbGpPWpGaD
Fluoxymesterone—Headache—Doxorubicin—ovarian cancer	3.22e-05	0.00223	CcSEcCtD
Fluoxymesterone—NR3C1—Gene Expression—NR5A1—ovarian cancer	3.19e-05	0.000474	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—VEGFA—ovarian cancer	3.19e-05	0.000474	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—CDKN1B—ovarian cancer	3.17e-05	0.000472	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—ERBB2—ovarian cancer	3.17e-05	0.000471	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—MTOR—ovarian cancer	3.14e-05	0.000467	CbGpPWpGaD
Fluoxymesterone—ESR1—AP-1 transcription factor network—IL6—ovarian cancer	3.14e-05	0.000467	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—CDKN1B—ovarian cancer	3.13e-05	0.000466	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—MTOR—ovarian cancer	3.13e-05	0.000465	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—PIK3CB—ovarian cancer	3.13e-05	0.000465	CbGpPWpGaD
Fluoxymesterone—ESR1—Generic Transcription Pathway—PARP1—ovarian cancer	3.11e-05	0.000462	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—CASP3—ovarian cancer	3.11e-05	0.000462	CbGpPWpGaD
Fluoxymesterone—ESR1—Leptin signaling pathway—HRAS—ovarian cancer	3.1e-05	0.000461	CbGpPWpGaD
Fluoxymesterone—AR—SIDS Susceptibility Pathways—VEGFA—ovarian cancer	3.1e-05	0.000461	CbGpPWpGaD
Fluoxymesterone—AR—Androgen receptor signaling pathway—AKT1—ovarian cancer	3.1e-05	0.000461	CbGpPWpGaD
Fluoxymesterone—NR3C1—Adipogenesis—CTNNB1—ovarian cancer	3.1e-05	0.00046	CbGpPWpGaD
Fluoxymesterone—NR3C1—AP-1 transcription factor network—IL6—ovarian cancer	3.09e-05	0.00046	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—CAV1—ovarian cancer	3.09e-05	0.00046	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—IL2—ovarian cancer	3.07e-05	0.000456	CbGpPWpGaD
Fluoxymesterone—NR3C1—Generic Transcription Pathway—PARP1—ovarian cancer	3.06e-05	0.000455	CbGpPWpGaD
Fluoxymesterone—Nausea—Doxorubicin—ovarian cancer	3.05e-05	0.00211	CcSEcCtD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—CCND1—ovarian cancer	3.03e-05	0.00045	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—CTNNB1—ovarian cancer	3e-05	0.000446	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—ESR1—ovarian cancer	2.98e-05	0.000443	CbGpPWpGaD
Fluoxymesterone—NR3C1—Glucocorticoid receptor regulatory network—TP53—ovarian cancer	2.98e-05	0.000442	CbGpPWpGaD
Fluoxymesterone—ESR1—Regulation of Telomerase—AKT1—ovarian cancer	2.96e-05	0.000441	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—CTNNB1—ovarian cancer	2.96e-05	0.00044	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—DLC1—ovarian cancer	2.95e-05	0.000439	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—CDKN1B—ovarian cancer	2.94e-05	0.000436	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—MYC—ovarian cancer	2.93e-05	0.000436	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—IL6ST—ovarian cancer	2.93e-05	0.000436	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—PTEN—ovarian cancer	2.92e-05	0.000434	CbGpPWpGaD
Fluoxymesterone—NR3C1—SIDS Susceptibility Pathways—CXCL8—ovarian cancer	2.9e-05	0.000431	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—CASP3—ovarian cancer	2.89e-05	0.00043	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—PTEN—ovarian cancer	2.88e-05	0.000429	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—MAPK1—ovarian cancer	2.87e-05	0.000426	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—EGFR—ovarian cancer	2.87e-05	0.000426	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—PIK3CG—ovarian cancer	2.82e-05	0.000419	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—APC—ovarian cancer	2.82e-05	0.000419	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—CCND1—ovarian cancer	2.82e-05	0.000418	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—CTNNB1—ovarian cancer	2.79e-05	0.000414	CbGpPWpGaD
Fluoxymesterone—NR3C1—SIDS Susceptibility Pathways—CASP3—ovarian cancer	2.78e-05	0.000412	CbGpPWpGaD
Fluoxymesterone—ESR1—Leptin signaling pathway—AKT1—ovarian cancer	2.74e-05	0.000407	CbGpPWpGaD
Fluoxymesterone—NR3C1—Glucocorticoid receptor regulatory network—IL6—ovarian cancer	2.72e-05	0.000405	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—PTEN—ovarian cancer	2.72e-05	0.000404	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—KRAS—ovarian cancer	2.71e-05	0.000403	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—PTEN—ovarian cancer	2.7e-05	0.000402	CbGpPWpGaD
Fluoxymesterone—NR3C1—Adipogenesis—STAT3—ovarian cancer	2.7e-05	0.000401	CbGpPWpGaD
Fluoxymesterone—Progesterone—ABCB1—ovarian cancer	2.69e-05	0.0096	CrCbGaD
Fluoxymesterone—NR3C1—SIDS Susceptibility Pathways—CTNNB1—ovarian cancer	2.68e-05	0.000398	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—ERBB2—ovarian cancer	2.64e-05	0.000392	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—VEGFA—ovarian cancer	2.64e-05	0.000392	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—STAT3—ovarian cancer	2.58e-05	0.000383	CbGpPWpGaD
Fluoxymesterone—ESR1—Regulation of nuclear SMAD2/3 signaling—AKT1—ovarian cancer	2.58e-05	0.000383	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—NRAS—ovarian cancer	2.57e-05	0.000382	CbGpPWpGaD
Fluoxymesterone—Testosterone—ABCB1—ovarian cancer	2.54e-05	0.00907	CrCbGaD
Fluoxymesterone—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—ovarian cancer	2.54e-05	0.000377	CbGpPWpGaD
Fluoxymesterone—NR3C1—Glucocorticoid receptor regulatory network—AKT1—ovarian cancer	2.51e-05	0.000374	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—MAPK3—ovarian cancer	2.5e-05	0.000371	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—PIK3CD—ovarian cancer	2.48e-05	0.000368	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—MAPK3—ovarian cancer	2.46e-05	0.000366	CbGpPWpGaD
Fluoxymesterone—Dexamethasone—ABCB1—ovarian cancer	2.46e-05	0.00878	CrCbGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—VEGFA—ovarian cancer	2.45e-05	0.000365	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—CDKN1B—ovarian cancer	2.45e-05	0.000363	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—MYC—ovarian cancer	2.43e-05	0.000361	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—NRAS—ovarian cancer	2.41e-05	0.000358	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—TP53—ovarian cancer	2.41e-05	0.000358	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—BCL9—ovarian cancer	2.41e-05	0.000358	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—CASP3—ovarian cancer	2.4e-05	0.000356	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—YAP1—ovarian cancer	2.4e-05	0.000356	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—MAPK1—ovarian cancer	2.38e-05	0.000353	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—EGFR—ovarian cancer	2.38e-05	0.000353	CbGpPWpGaD
Fluoxymesterone—NR3C1—SIDS Susceptibility Pathways—VEGFA—ovarian cancer	2.35e-05	0.00035	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—MAPK1—ovarian cancer	2.34e-05	0.000348	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—EGFR—ovarian cancer	2.34e-05	0.000348	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—CCND1—ovarian cancer	2.33e-05	0.000347	CbGpPWpGaD
Fluoxymesterone—AR—Generic Transcription Pathway—ESR1—ovarian cancer	2.32e-05	0.000345	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—CTNNB1—ovarian cancer	2.31e-05	0.000343	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—MAPK3—ovarian cancer	2.31e-05	0.000343	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—MYC—ovarian cancer	2.26e-05	0.000336	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—PTEN—ovarian cancer	2.25e-05	0.000335	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—KRAS—ovarian cancer	2.24e-05	0.000334	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—KRAS—ovarian cancer	2.21e-05	0.000329	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—MAPK1—ovarian cancer	2.21e-05	0.000328	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—EGFR—ovarian cancer	2.21e-05	0.000328	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—MAPK1—ovarian cancer	2.2e-05	0.000327	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—EGFR—ovarian cancer	2.2e-05	0.000327	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—ERBB2—ovarian cancer	2.19e-05	0.000325	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—PIK3CB—ovarian cancer	2.16e-05	0.000321	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—MTOR—ovarian cancer	2.16e-05	0.000321	CbGpPWpGaD
Fluoxymesterone—AR—SIDS Susceptibility Pathways—IL6—ovarian cancer	2.15e-05	0.000319	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—PGR—ovarian cancer	2.09e-05	0.000311	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—KRAS—ovarian cancer	2.09e-05	0.00031	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—KRAS—ovarian cancer	2.08e-05	0.000308	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—CXCL8—ovarian cancer	2.07e-05	0.000308	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—PIK3CA—ovarian cancer	2.06e-05	0.000306	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—PIK3CA—ovarian cancer	2.03e-05	0.000302	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—VEGFA—ovarian cancer	2.03e-05	0.000302	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—AKT1—ovarian cancer	2.03e-05	0.000302	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—CDKN1B—ovarian cancer	2.03e-05	0.000301	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—TP53—ovarian cancer	1.99e-05	0.000296	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—CASP3—ovarian cancer	1.98e-05	0.000295	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—IL2—ovarian cancer	1.98e-05	0.000295	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—PARP1—ovarian cancer	1.94e-05	0.000289	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—CCND1—ovarian cancer	1.93e-05	0.000287	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—MAPK3—ovarian cancer	1.92e-05	0.000286	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—CTNNB1—ovarian cancer	1.91e-05	0.000284	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—PIK3CA—ovarian cancer	1.91e-05	0.000283	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—DOK1—ovarian cancer	1.9e-05	0.000283	CbGpPWpGaD
Fluoxymesterone—NR3C1—Adipogenesis—IL6—ovarian cancer	1.88e-05	0.00028	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—HRAS—ovarian cancer	1.88e-05	0.00028	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—MMP9—ovarian cancer	1.88e-05	0.000279	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—MYC—ovarian cancer	1.87e-05	0.000278	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—PTEN—ovarian cancer	1.86e-05	0.000277	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—TP53—ovarian cancer	1.85e-05	0.000276	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—YAP1—ovarian cancer	1.85e-05	0.000274	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—MAPK1—ovarian cancer	1.83e-05	0.000272	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—EGFR—ovarian cancer	1.83e-05	0.000272	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—YAP1—ovarian cancer	1.82e-05	0.00027	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—IL6—ovarian cancer	1.8e-05	0.000268	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—PPP1CC—ovarian cancer	1.79e-05	0.000266	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—HRAS—ovarian cancer	1.76e-05	0.000262	CbGpPWpGaD
Fluoxymesterone—NR3C1—Generic Transcription Pathway—ESR1—ovarian cancer	1.76e-05	0.000262	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—KRAS—ovarian cancer	1.73e-05	0.000257	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—IL6—ovarian cancer	1.69e-05	0.000251	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—AKT1—ovarian cancer	1.68e-05	0.00025	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—VEGFA—ovarian cancer	1.68e-05	0.00025	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—STAT3—ovarian cancer	1.67e-05	0.000248	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—NRAS—ovarian cancer	1.66e-05	0.000247	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—AKT1—ovarian cancer	1.66e-05	0.000247	CbGpPWpGaD
Fluoxymesterone—NR3C1—SIDS Susceptibility Pathways—IL6—ovarian cancer	1.63e-05	0.000242	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—PGR—ovarian cancer	1.61e-05	0.000239	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—MAPK3—ovarian cancer	1.59e-05	0.000237	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—PIK3CA—ovarian cancer	1.59e-05	0.000236	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—PGR—ovarian cancer	1.59e-05	0.000236	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—PPP2R1A—ovarian cancer	1.58e-05	0.000234	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—AKT1—ovarian cancer	1.57e-05	0.000233	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—AKT1—ovarian cancer	1.56e-05	0.000232	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—MYC—ovarian cancer	1.55e-05	0.00023	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—TP53—ovarian cancer	1.54e-05	0.000228	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—MAPK1—ovarian cancer	1.52e-05	0.000225	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—EGFR—ovarian cancer	1.52e-05	0.000225	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—PARP1—ovarian cancer	1.5e-05	0.000223	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—PARP1—ovarian cancer	1.48e-05	0.000219	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—KRAS—ovarian cancer	1.43e-05	0.000213	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—HDAC6—ovarian cancer	1.36e-05	0.000201	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—PIK3CA—ovarian cancer	1.32e-05	0.000196	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—AKT1—ovarian cancer	1.3e-05	0.000193	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—TP53—ovarian cancer	1.27e-05	0.000189	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—HRAS—ovarian cancer	1.22e-05	0.000181	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—PPP2R1A—ovarian cancer	1.22e-05	0.000181	CbGpPWpGaD
Fluoxymesterone—AR—Generic Transcription Pathway—MYC—ovarian cancer	1.21e-05	0.000179	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—YAP1—ovarian cancer	1.2e-05	0.000178	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—PPP2R1A—ovarian cancer	1.2e-05	0.000178	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—XIAP—ovarian cancer	1.18e-05	0.000175	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—IL6—ovarian cancer	1.16e-05	0.000173	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—SMARCA4—ovarian cancer	1.15e-05	0.00017	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—EREG—ovarian cancer	1.12e-05	0.000166	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—ESR1—ovarian cancer	1.12e-05	0.000166	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—AKT1—ovarian cancer	1.07e-05	0.00016	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—PGR—ovarian cancer	1.05e-05	0.000156	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—PARP1—ovarian cancer	9.74e-06	0.000145	CbGpPWpGaD
Fluoxymesterone—ESR1—Generic Transcription Pathway—MYC—ovarian cancer	9.29e-06	0.000138	CbGpPWpGaD
Fluoxymesterone—NR3C1—Generic Transcription Pathway—MYC—ovarian cancer	9.15e-06	0.000136	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—ESR1—ovarian cancer	8.47e-06	0.000126	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—PPP2R1A—ovarian cancer	7.9e-06	0.000117	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—TERT—ovarian cancer	6.28e-06	9.33e-05	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—MAPK3—ovarian cancer	5.97e-06	8.88e-05	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—MYC—ovarian cancer	5.81e-06	8.63e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CAV1—ovarian cancer	5.81e-06	8.63e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—IL6ST—ovarian cancer	5.5e-06	8.18e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—APC—ovarian cancer	5.29e-06	7.86e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—PIK3CG—ovarian cancer	5.29e-06	7.86e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—PIK3CD—ovarian cancer	4.65e-06	6.91e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—MAPK3—ovarian cancer	4.6e-06	6.84e-05	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—MAPK3—ovarian cancer	4.53e-06	6.73e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—MYC—ovarian cancer	4.48e-06	6.65e-05	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—MYC—ovarian cancer	4.41e-06	6.55e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—ERBB2—ovarian cancer	4.11e-06	6.1e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—MTOR—ovarian cancer	4.05e-06	6.02e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—PIK3CB—ovarian cancer	4.05e-06	6.02e-05	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—AKT1—ovarian cancer	4.03e-06	5.99e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CXCL8—ovarian cancer	3.89e-06	5.79e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CDKN1B—ovarian cancer	3.8e-06	5.65e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CASP3—ovarian cancer	3.73e-06	5.54e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—IL2—ovarian cancer	3.72e-06	5.53e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CCND1—ovarian cancer	3.63e-06	5.39e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CTNNB1—ovarian cancer	3.59e-06	5.34e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—MMP9—ovarian cancer	3.52e-06	5.23e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—PTEN—ovarian cancer	3.5e-06	5.2e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—VEGFA—ovarian cancer	3.16e-06	4.7e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—STAT3—ovarian cancer	3.13e-06	4.65e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—NRAS—ovarian cancer	3.12e-06	4.64e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—AKT1—ovarian cancer	3.1e-06	4.61e-05	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—AKT1—ovarian cancer	3.06e-06	4.54e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—MAPK3—ovarian cancer	2.99e-06	4.45e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—MYC—ovarian cancer	2.91e-06	4.32e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—MAPK1—ovarian cancer	2.85e-06	4.23e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—EGFR—ovarian cancer	2.85e-06	4.23e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—KRAS—ovarian cancer	2.69e-06	4e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—PIK3CA—ovarian cancer	2.47e-06	3.67e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—TP53—ovarian cancer	2.39e-06	3.55e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—HRAS—ovarian cancer	2.29e-06	3.4e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—IL6—ovarian cancer	2.19e-06	3.25e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—AKT1—ovarian cancer	2.02e-06	3e-05	CbGpPWpGaD
